Handling Drug Price Spikes: A Sad Place To Be
This article was originally published in Scrip
When Valeant Pharmaceuticals International Inc. suddenly raised the prices of two critical drugs in the hospital setting, Nitropress (sodium nitroprusside) and Isuprel (isoprenaline), facilities had to find a way to deal with ensuring they had those vital medicines available, but doing so without breaking the bank.
You may also be interested in...
Marathon's High-Priced Window May Not Stay Open Long
Ongoing trial is intended to compare the newly approved steroid Emflaza with prednisone in DMD for efficacy and safety.
Excessive Drug Pricing: What It Is, And What It Isn't
It's difficult to know exactly how to define "excessive" or "unfair" pricing where pharmaceutical products are concerned, and many factors have to be taken into account. Even the EU Commission and competition authorities may be reluctant to pursue cases of alleged price gouging, lawyer David Hull told Informa's recent EU Pharma Law Forum in Brussels.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.